三阴性乳腺癌
米托蒽醌
乳腺癌
医学
癌症研究
癌症
三重阴性
肿瘤科
内科学
化疗
作者
Hongjie Zhang,Rui Geng,Benyan Zheng,Jing Wang,Yuan Z. Hu,Xiaopeng Ma
标识
DOI:10.1021/acsanm.4c06594
摘要
Mitoxantrone (MTO)-based combination therapies hold great promise in enhancing therapeutic outcomes for aggressive cancers, such as triple-negative breast cancer (TNBC). In this study, we designed a core–shell nanoparticle system (MTO@IR780@BSA-GA-Fe@PLGA, PMIBs) that integrates MTO chemotherapy, sonodynamic therapy (SDT) via IR780, and Fenton reaction-enhanced oxidative stress. The system demonstrated pH-responsive release of therapeutic agents, mitochondrial targeting, and synergistic anticancer effects when combined with ultrasound (US) irradiation. PMIBs significantly enhanced reactive oxygen species (ROS) production, increased mitochondrial damage, and improved apoptosis rates, resulting in a tumor growth inhibition rate far superior to that of conventional treatments. These findings highlight the potential of this US-enhanced nanoplatform in addressing challenges associated with TNBC treatment, offering a highly effective and minimally invasive therapeutic strategy.
科研通智能强力驱动
Strongly Powered by AbleSci AI